Indian firm Aurobindo Pharma has entered into a definitive agreement to sell its US subsidiary Natrol to an affiliate of New Mountain Capital in an all-cash transaction valued at Rs40.48bn ($550m).
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an affiliate of New Mountain Capital to combine with Jarrow Formulas.